Trial Form Support S.L.   Report issue

For profit Phase 2 Phase 3
Founded: Lund Sweden (1996)

Organization Overview

First Clinical Trial
2005
NCT00251381
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenocarcinoma (Phase 2)

Anus Neoplasms (Phase 2)

Carcinoma (Phase 2)

Carcinoma, Renal Cell (Phase 2)

Carcinoma, Squamous Cell (Phase 2)

Esophageal Neoplasms (Phase 2)

Head and Neck Neoplasms (Phase 2)

Oropharyngeal Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 6
  • # of Trial APIs: 12